The funding committees for the NIHR Invention for Innovation (i4i) Programme are multidisciplinary, comprising academic, clinical and commercial experts, as well as patient and public members. i4i has four committees: three for Product Development Awards (committee A, committee B and committee C), and one for Connect.
Committee members - Product Development Awards Selection Committee B
| Name | Position | Organisation | Expertise |
|---|---|---|---|
|
Dr Charles Spicer (Chair) |
Chair |
CREO Medical Group PLC |
Dr Spicer is an experienced chair, director and adviser to public and private companies focused on the life science and medical technology sectors. |
|
Professor Liam Grover (Deputy Chair) |
Professor of Biomaterials Science and Director of the Healthcare Technologies Institute |
University of Birmingham |
Professor Grover is a biomaterials scientist whose research focuses on designing materials that enhance the tissue regeneration process. |
|
Professor Keith Abrams |
Professor of Statistics and Data Science |
University of Warwick |
Professor Abrams has expertise in biostatistics, health technology assessment, health data science and real world evidence. |
|
Mr David Branagh |
Founder |
Raidmed Ltd |
Mr Branagh was the engineering director at a wearable device spin-out company and has experience in bringing a product through commercialisation. |
|
Mr Mark Campbell |
Independent Healthtech Consultant |
Self-employed |
Mr Campbell advises companies, life science organisations and public sector agencies on value proposition development, evidence generation and health technology assessment for devices, diagnostics and digital health technologies. |
|
Ms Jenny Chong |
Non-Executive Director
|
Medway NHS Foundation Trust |
Ms Chong has over 20 years experience in investment banking with expertise in Technology, Big Data and AI. |
|
Ms Lucy Davies |
Head of Clinical Strategy |
Lucida Medical Ltd |
Ms Davies is a medical statistician and has expertise in developing clinical trials in a range of health areas including cancer and surgery. She has a commercial background in the evaluation of digital health technologies and AI. |
|
Mr Michael Duffin |
Director of Client Success |
Inicio Health LTD |
Mr Duffin has a clinical background in physiotherapy, and a commercial background with experience in pathway transformation, real world evaluation, and digital health. |
|
Dr Serge Engamba |
Clinical Research Lead, Primary Care Specialty Lead |
Norwich Primary Care Network, CRN East of England Core Team |
Dr Engamba has a clinical and research (delivery) background and has experience in implementing clinical trials in primary care and conducting commercial research. |
|
Mrs Katrina Goodhand |
Public Committee Member |
PPI Representative |
PPI Representative |
|
Dr Zarnie Khadjesari |
Associate Professor in Health Sciences |
University of East Anglia |
Dr Khadjesari has expertise in digital health research and implementation science. She is experienced in both quantitative and qualitative research methods. |
|
Dr Amrita Kumar |
Consultant Radiologist and Clinical Lead AI |
Frimley Health NHS Foundation Trust |
Dr Kumar is a consultant radiologist with a speciality in breast cancer screening. She has expertise in AI and looking at how products can fit into the pathway. |
|
Professor Paul Leeson |
Professor of Cardiovascular Medicine, University of Oxford |
University of Oxford |
Professor Leeson is a consultant cardiologist with expertise in using AI and imaging to develop novel approaches to cardiovascular disease management. |
|
Dr Stephen Lynn |
Associate Commercial Director |
Health Innovation North East and North Cumbria |
Dr Lynn has experience in supporting the development of diagnostics and medical devices and has expertise in adoption and real world evaluation. |
|
Professor Arshad Majid |
Professor of Cerebrovascular Neurology and Consultant Neurologist |
University of Sheffield |
Professor Majid is a Neurologist and Stroke specialist who focuses on translational neuroscience research including cerebrovascular disease and neuroinflammation. |
|
Professor Luca Marciani |
Professor of Gastrointestinal Imaging |
University of Nottingham |
Professor Marciani is a physicist with expertise in biomedical and translational imaging research and particular interests in magnetic resonance imaging and medical devices. |
|
Mr Mark O'Neil |
Public Committee Member |
PPI Representative |
PPI Representative |
|
Professor Amar Rangan |
Professor of Orthopaedic Surgery |
Universities of York and Oxford |
Professor Rangan is a specialist shoulder and elbow surgeon and has experience in clinical effectiveness and translational research. |
|
Professor Mike Reed |
Orthopaedic Surgeon |
Northumbria Healthcare NHS Foundation Trust and University of York |
Professor Reed is an orthopaedic Surgeon with experience in data and clinical research. He is the clinical lead for machine learning based projects. |
|
Dr Chris Sampson |
Senior Principal Economist |
Office of Health Economics |
Dr Sampson is an expert in health economic evaluation, with a particular interest in mental health and digital therapeutics. |
|
Ms Helen Lewis-White |
Deputy Director of Research |
North Bristol NHS Trust |
Ms Lewis-White’s background is in nursing and neuroscience. She has expertise in clinical trials and experience in implementation of medical technologies. |
|
Dr Neville Young |
Director of Enterprise & Innovation |
Health Innovation Yorkshire and Humber |
Dr Young has experience with innovative surgical tools, intraoperative imaging systems, novel biosensing diagnostics, nanotechnology and remote monitoring. |